Ascletis Pharma Plans to Buy Back Up to HK$300M of Shares on Open Market
Ascletis Pharma Plans to Buy Back Up to HK$300M of Shares on Open Market
Ascletis Pharma Plans to Buy Back Up to HK$300M of Shares on Open Market
Ascletis Pharma: Board Says Current Share Price Doesn't Reflect Intrinsic Value
Mineral Resources Target Price Cut 4.8% to A$79.00/Share by UBS>MIN.AU
Sandfire Resources Target Price Raised 3.5% to A$20.70/Share by UBS>SFR.AU
Whitehaven Coal Target Price Cut 4.4% to A$8.70/Share by UBS>WHC.AU
Alcoa Target Price Cut 14% to A$95.00/Share by UBS>AAI.AU
South32 Target Price Cut 2% to A$5.00/Share by UBS>S32.AU
Fortescue Metals Target Price Raised 1.5% to A$19.70/Share by UBS>FMG.AU
Rio Tinto Target Price Cut 3.3% to A$177.00/Share by UBS>RIO.AU
Chalice Mining Target Price Cut 33% to A$2.00/Share by UBS>CHN.AU
Alkane Resources Target Price Cut 6.5% to A$2.15/Share by UBS>ALK.AU
Southern Cross Gold Target Price Cut 2% to A$12.25/Share by UBS>SX2.AU
Catalyst Metals Target Price Cut 2.7% to A$9.00/Share by UBS>CYL.AU
Minerals 260 Target Price Raised 4.5% to A$1.15/Share by UBS>MI6.AU
Pantoro Gold Target Price Cut 18% to A$5.10/Share by UBS >PNR.AU
Bellevue Gold Target Price Cut 20% to A$1.80/Share by UBS>BGL.AU
Westgold Resources Target Price Cut 2.9% to A$8.25/Share by UBS>WGX.AU
Vault Minerals Target Price Cut 19% to A$5.70/Share by UBS>VAU.AU
Regis Resources Target Price Cut 3.4% to A$8.45/Share by UBS>RRL.AU
Greatland Resources Target Price Cut 4.5% to A$15.75/Share by UBS>GGP.AU